ThinkGen’s Client wants to assess the possibility of a prophylactic product post infectious disease exposure, taking into account susceptibility across specific populations of higher risk, and determine various elements that may lead to increased consideration and use.
We began by recognizing the current attitudes, perceptions, and approach of HCPs regarding the treatment of this infectious disease in order to uncover its potential and pinpoint the many elements that influence the customer and stakeholder choice. Furthermore, we explored HCP perceptions of current prevention efforts, assessed potential prophylactic strategies, and explored baseline TPP reactions utilizing ThinkGen’s ThinkTPP.